Impact of the 21-Gene Assay in Patients with High-Clinical Risk ER-Positive and HER2-Negative Early Breast Cancer: Results of the KARMA Dx Study

  1. Llombart-Cussac, A.
  2. Anton-Torres, A.
  3. Rojas, B.
  4. Andrés, R.
  5. Martinez, N.
  6. Rodríguez, C.A.
  7. Marin, S.
  8. Puértolas, T.
  9. González, A.F.
  10. Fernández-Murga, M.L.
  11. Hagen, C.
  12. Ruiz-Borrego, M.
Journal:
Cancers

ISSN: 2072-6694

Year of publication: 2023

Volume: 15

Issue: 5

Type: Article

DOI: 10.3390/CANCERS15051529 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals